Relapse risk doubles in UC patients with histologic inflammation

“In this large, multicenter, real-world study including both academic
and community practices using standard-of-care reports, histologic
inflammation — despite endoscopic remission — independently
conveyed a two-fold increased risk for subsequent relapse within a
year,” Benjamin Click, assistant professor at the University of
Colorado Crohn’s and Colitis Center and School of Medicine, told
Healio.